pharmaceutical investing Oragenics Resumes Phase 2 Clinical Trial of AG013 in Oral Mucositis Following Positive Routine Safety Review
CoTec Holdings Corp. Announces Partial Settlement and Amendment and Restatement of Convertible Loan Facilities
Westport to Showcase High?Pressure CNG Fuel System for North American Heavy?Duty Fleets at ACT Expo 2026